# Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer

> **NCT02635971** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 168 (estimated)

## Conditions studied

- Carcinoma, Pancreatic

## Interventions

- **PROCEDURE:** Transcatheter arterial infusion
- **PROCEDURE:** Intravenous chemotherapy
- **DRUG:** Gemcitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT02635971
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2022-06
- **Final completion:** 2022-12
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2020-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02635971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02635971, "Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02635971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*